Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Panel Rejects Vivus’s Qnexa, Citing Safety Worries
FDA Panel Rejects Vivus’s Qnexa, Citing Safety Worries
FDA Panel Rejects Vivus’s Qnexa, Citing Safety Worries
Submitted by
admin
on July 15, 2010 - 6:04pm
Source:
WSJ Online
News Tags:
FDA
obesity
Vivus
Qnexa
advisory panels
Orexigen
Arena Pharmaceuticals
Contrave
Headline:
FDA Panel Rejects Vivus’s Qnexa, Citing Safety Worries
Do Not Allow Advertisers to Use My Personal information
